CHEMICAL AND PHYSICAL PROPERTIES
Physical Description | Solid |
---|---|
Solubility | Sparingly soluble in water |
LogP | 0.13 |
Stability/Shelf Life | Stable under recommended storage conditions. /Rosuvastatin calcium/ |
Optical Rotation | White powder from water as the monohydrate; begins to melt at 155 °C with no definitive MP. Specific optical rotation: +14.8 deg at 24 °C/D (c = 1.012 in 50% methanol). Sparingly soluble in water, methanol; slightly soluble in ethanol /Rosuvastatin calcium salt/ |
Ionization Efficiency | Positive |
Other Experimental Properties | pKa = 4.76; log Kow = 0.26-0.30 at pH 7.0. Solubility in water: 3820 mg/L (pH 5), 22,000 mg/L (pH 7), 4860 mg/l (pH 9). /Rosuvastatin calcium/ |
COMPUTED DESCRIPTORS
Molecular Weight | 481.5 g/mol |
---|---|
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 481.16828496 g/mol |
Monoisotopic Mass | 481.16828496 g/mol |
Topological Polar Surface Area | 149 Ų |
Heavy Atom Count | 33 |
Formal Charge | 0 |
Complexity | 767 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently-Bonded Unit Count | 1 |
Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
Rosuvastatin is a dihydroxy monocarboxylic acid that is (6E)-7-{4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl} hept-6-enoic acid carrying two hydroxy substituents at positions 3 and 5 (the 3R,5S-diastereomer). It has a role as an antilipemic drug, an anti-inflammatory agent, a CETP inhibitor, a cardioprotective agent, a xenobiotic and an environmental contaminant. It is a member of pyrimidines, a sulfonamide, a dihydroxy monocarboxylic acid, a statin (synthetic) and a member of monofluorobenzenes. It is functionally related to a hept-6-enoic acid. It is a conjugate acid of a rosuvastatin(1-).